Mercury Biopharmaceutical Corporation (TPEX: 6932)
15.60
+0.40 (2.63%)
Sep 10, 2024, 2:46 PM CST
Mercury Biopharmaceutical Market Cap
Mercury Biopharmaceutical has a market cap or net worth of 6.47 billion as of September 10, 2024. Its market cap has decreased by -22.27% in one year.
Market Cap
6.47B
Enterprise Value
6.24B
Revenue
5.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.60
Market Cap Chart
Since December 23, 2022, Mercury Biopharmaceutical's market cap has increased from 5.10B to 6.47B, an increase of 26.69%. That is a compound annual growth rate of 14.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 10, 2024 | 6.47B | -16.87% |
Dec 29, 2023 | 7.78B | 94.15% |
Dec 30, 2022 | 4.01B | -21.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition